| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443998 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
Patients with low SMI have shorter survival. Gender and SMI strengthens the accuracy of MDACC or RMH scores as prognostic tools. Prospective validation of these findings is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
H. Veasey Rodrigues, V.E. Baracos, J.J. Wheler, H.A. Parsons, D.S. Hong, A. Naing, S. Fu, G. Falchoock, A.M. Tsimberidou, S. Piha-Paul, G. Chisholm, R. Kurzrock,